Argent Trust’s Novartis NVS Stock Holding History

Argent Trust’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$1.07M	Buy	14,772 +482	+3%	+$36.7K	0.29%	85
2017 Q4	$1.07M	Sell	14,290 -65	-0.5%	-$4.9K	0.29%	88
2017 Q3	$1.1M	Buy	14,355 +11	+0.1%	+$831	0.3%	87
2017 Q2	$1.07M	Sell	14,344 -4,924	-26%	-$349K	0.3%	90
2017 Q1	$1.28M	Buy	19,268 +1,126	+6%	+$75K	0.36%	75
2016 Q4	$1.18M	Buy	18,142 +3,509	+24%	+$228K	0.34%	77
2016 Q3	$1.03M	Sell	14,633 -352	-2%	-$25.6K	0.31%	82
2016 Q2	$1.11M	Sell	14,985 -2,014	-12%	-$139K	0.35%	81
2016 Q1	$1.1M	Buy	16,999 +434	+3%	+$29.5K	0.35%	77
2015 Q4	$1.28M	Buy	+16,565	New	+$1.32M	0.42%	69
2015 Q3	–	Sell	-2,417	Closed	-$213K	–	117
2015 Q2	$213K	Hold	2,417	–	–	0.21%	107
2015 Q1	$214K	Hold	2,417	–	–	0.21%	101
2014 Q4	$201K	Buy	+2,417	New	+$200K	0.18%	104

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Argent Trust's NVS Position: Q1 2018 in Review

Argent Trust increased its Novartis (NVS) stake by 3.4% in Q1 2018, buying an estimated $36.7K and bringing the position to 14,772 shares worth $1.07M. The position accounts for 0.29% of the portfolio, ranked #85.

Argent Trust first reported a position in NVS in Q4 2014 and has held it in 13 quarters since. The position peaked at $1.28M in Q1 2017. 1,012 funds tracked by Wall St. Rank hold NVS as of Q1 2018.

Argent Trust held 14,772 shares of Novartis worth $1.07M as of Q1 2018.
Argent Trust bought 482 Novartis shares in Q1 2018, an estimated $36.7K.
Novartis made up 0.29% of Argent Trust's portfolio in Q1 2018, its #85 holding.
Argent Trust first reported a position in Novartis in Q4 2014 and has held it in 13 quarters since.
Argent Trust's Novartis position peaked at $1.28M in Q1 2017.
1,012 funds tracked by Wall St. Rank held Novartis as of Q1 2018.

Based on Argent Trust's 13F filing for Q1 2018, filed 11 May 2018.